The Source Blog
Recent Action in Pharmaceuticals
HB 690 – Georgia
Introduced: 2025 Status: In Process
This bill amends Georgia’s pharmacy benefits manager (PBM) regulations by establishing a comprehensive set of duties and responsibilities for PBMs. The bill expands the definitions of key terms related to pharmacy benefits management and introduces […]
HB 810 – Georgia
Introduced: 2025 Status: In Process
This bill requires pharmacy benefits managers (PBMs) to ensure that final reimbursements to pharmacies for prescription drugs are based on specific formulas designed to protect pharmacies from receiving inadequate compensation. The bill mandates that reimbursement […]
HB 931 – Georgia
Introduced: 2025 Status: In Process
This bill establishes a Prescription Drug Affordability Board in Georgia to help control high prescription drug costs, addressing concerns about how expensive medications negatively impact residents’ health and economic well-being. The board will have five […]
SB 60 – Georgia
Introduced: 2025 Status: In Process
This bill amends Georgia’s pharmacy benefits manager (PBM) regulations by establishing a comprehensive set of duties and responsibilities for PBMs in their interactions with insureds, health plans, and providers. The bill significantly expands definitions related […]
SF 264 – Iowa
Introduced: 2025 Status: In Process
This bill establishes a Prescription Drug Affordability Board (board) to help protect state residents, healthcare providers, and other stakeholders from high prescription drug costs. The board will consist of five members appointed by the governor, […]
HB 1443 – Illinois
Introduced: 2025 Status: In Process
This bill creates the Health Care Availability and Access Board (HAAB) to help manage and control prescription drug costs in Illinois. The board will consist of five members appointed by the Governor, who must have […]
SB 0066 – Illinois
Introduced: 2025 Status: In Process
This bill creates the Health Care Availability and Access Board, an independent state government body designed to address high prescription drug costs. The Board will have five members appointed by the Governor who have expertise […]
Previous | Next | See all Legislation Records
Introduced: 2025 Status: In Process
This bill amends Georgia’s pharmacy benefits manager (PBM) regulations by establishing a comprehensive set of duties and responsibilities for PBMs. The bill expands the definitions of key terms related to pharmacy benefits management and introduces […]
HB 810 – Georgia
Introduced: 2025 Status: In Process
This bill requires pharmacy benefits managers (PBMs) to ensure that final reimbursements to pharmacies for prescription drugs are based on specific formulas designed to protect pharmacies from receiving inadequate compensation. The bill mandates that reimbursement […]
HB 931 – Georgia
Introduced: 2025 Status: In Process
This bill establishes a Prescription Drug Affordability Board in Georgia to help control high prescription drug costs, addressing concerns about how expensive medications negatively impact residents’ health and economic well-being. The board will have five […]
SB 60 – Georgia
Introduced: 2025 Status: In Process
This bill amends Georgia’s pharmacy benefits manager (PBM) regulations by establishing a comprehensive set of duties and responsibilities for PBMs in their interactions with insureds, health plans, and providers. The bill significantly expands definitions related […]
SF 264 – Iowa
Introduced: 2025 Status: In Process
This bill establishes a Prescription Drug Affordability Board (board) to help protect state residents, healthcare providers, and other stakeholders from high prescription drug costs. The board will consist of five members appointed by the governor, […]
HB 1443 – Illinois
Introduced: 2025 Status: In Process
This bill creates the Health Care Availability and Access Board (HAAB) to help manage and control prescription drug costs in Illinois. The board will consist of five members appointed by the Governor, who must have […]
SB 0066 – Illinois
Introduced: 2025 Status: In Process
This bill creates the Health Care Availability and Access Board, an independent state government body designed to address high prescription drug costs. The Board will have five members appointed by the Governor who have expertise […]
Previous | Next | See all Legislation Records
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the […]
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase […]
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are […]
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans […]
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass […]
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing […]
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act […]
Next | See all Litigation Records
News & Opinions
Articles & Reports
New England Journal of Medicine
March 22, 2025
JAMA Network February 28, 2025
Health Affairs Forefront January 14, 2025
Value in Health Journal December 1, 2024
JAMA Network February 28, 2025
Health Affairs Forefront January 14, 2025
Value in Health Journal December 1, 2024
Trends in Pharmaceuticals
2019 Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Transparency
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Rate Setting
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Gouging
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Drug Importation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharmacy Gag Clause Regulation
Gag clause regulation includes laws that allow pharmacists to disclose costs to insured patients and those that prohibit pharmacists from collecting more in cost-sharing from the insured patient than the cash price. See The Source’s Spotlight on 2018 State Drug Legislation Part 3 and 2018 legislation chart for more information.
-
Key:
- Enacted
- Considered
- No Legislative Session
PBM Regulation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharma Other
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session